Gnosis by Lesaffre Leads Innovation in Women’s Health at Expo West 2026
Women’s health is a central focus at Natural Products Expo West 2026, with Gnosis by Lesaffre showcasing ingredients designed to support women’s wellness throughout their lifecycles. The company is highlighting solutions for prenatal health, digestion, bone density, heart health, vaginal health, and brain health at the trade present in Anaheim, California, from March 4-6, 2026 [Gnosis by Lesaffre].
A Shift Towards Lifecycle-Driven Wellness
According to Alina Slotnik, marketing director for the Americas at Gnosis by Lesaffre, the industry is moving beyond traditional approaches focused solely on prenatal and menopausal stages. “Women’s wellness is moving beyond prenatal and menopause silos toward a continuous, lifecycle-driven approach to health,” Slotnik stated. “Women today are taking greater ownership of their well-being, prioritizing proactive self-care and everyday health needs that extend well beyond hormonal milestones.” [Nutrition Insight]
This shift is reflected in increased supplement usage, with a majority of women worldwide proactively using supplements to maintain their health. Current top concerns for women include weight management, stress, digestive health, and metabolic health, often ranking higher than hormone balance, indicating a demand for more holistic solutions. [Nutrition Insight]
Key Ingredients and Innovations
Gnosis by Lesaffre is presenting several key ingredients at Expo West 2026, including Landkind™ Pure Salidroside, Red Star® Nutritional Yeast, and MenaQ7® Vitamin K2 as MK-7, alongside their clinically proven biotic solutions, ibSium® and Quatreflora®. [Gnosis by Lesaffre]
MenaQ7® Vitamin K2
The company’s MenaQ7® vitamin K2 solution addresses both bone density and arterial flexibility through a single, clinically validated mechanism. Clinical evidence confirms cardiovascular benefits, as it aids the body in utilizing calcium and inhibiting calcification. Research partners are also exploring a potential connection between MenaQ7® and brain health, with seven trials currently underway. [Nutrition Insight]
Adonat Premium SAMe
Gnosis by Lesaffre’s Adonat Premium SAMe (S-adenosyl-L-methionine) exemplifies a move towards ingredients that address underlying biological pathways, delivering benefits across multiple health systems, including mood, cognitive function, cardiovascular support, joint and bone health, and menopausal comfort. [Nutrition Insight]
Quatrefolic® Bioactive Folate
Highlighting the importance of bioavailability, Gnosis by Lesaffre is showcasing Quatrefolic®, a stabilized bioactive folate form (5-methyltetrahydrofolate or 5-MTHF). This form bypasses the enzyme-dependent conversion of folic acid, ensuring consistent bioavailability across different genetic profiles. Approximately 40% of the population cannot efficiently convert folic acid into 5-MTHF, potentially limiting its efficacy and contributing to elevated homocysteine levels. [Nutrition Insight]
Targeting the Vaginal Microbiome
Gnosis by Lesaffre is also focusing on innovations for vaginal health, recognizing the growing awareness of the vaginal microbiome. The company is shifting towards targeted, site-specific solutions addressing intimate health concerns, rather than generalized gut health approaches. In 2024, over half of women’s health supplements containing probiotics targeted vaginal health, with significant growth in products supporting vaginal and urinary tract health. [Nutrition Insight]
Their Quatreflora, a specialized probiotic yeast, has demonstrated clinical benefits for women experiencing yeast infections caused by Candida albicans, offering advantages over traditional probiotic supplements. [Nutrition Insight]
Digestive Support for GLP-1 Users
Recognizing the increasing use of GLP-1 medications and the digestive issues that can accompany them, Gnosis by Lesaffre is highlighting digestive support as a crucial companion strategy. Women are more likely to use GLP-1s and are also more prone to digestive disorders like IBS. IbSium®, supported by multiple clinical trials and a meta-analysis, has shown significant reductions in abdominal pain and bowel irregularity, with 77% of users reporting improvement within 15 days. [Nutrition Insight]
Looking Ahead
Gnosis by Lesaffre aims to empower women to thrive at every life stage by focusing on clinically validated, lifecycle-relevant solutions and multifunctional ingredients that address root biological pathways. By embracing a holistic approach and prioritizing scientific rigor, the company is positioned to meet the evolving needs of the women’s health market. [Nutrition Insight]